Metallothionein 2A (MT2A) Controls Cell Proliferation and Liver Metastasis by Controlling the MST1/LATS2/YAP1 Signaling Pathway in Colorectal Cancer

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2022 Jun 1

PMID 35642057

Authors

Xi Liu

Jun Quan

Zhaolong Shen

Zequn Zhang

Zhijian Chen

Liang Li

Xiaorong Li

Gui Hu

Xiaofeng Deng

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) is one of the three major cancers in the world and is the cancer with the most liver metastasis. The present study aimed to investigate the role of metallothionein 2A (MT2A) in the modulation of CRC cell proliferation and liver metastasis, as well as its molecular mechanisms.

Methods: The expression profile of metallothionein 2A (MT2A) in colorectal cancer retrieved from TCGA, GEO and Oncomine database. The biological effect of MT2A overexpression was investigated mainly involving cell proliferation and migration in CRC cells as well as growth and metastasis in CRC animal models. To explore the specific mechanism of MT2A metastasis in CRC, transcriptome sequencing was used to compare the overall expression difference between the control group and the MT2A overexpression group.

Results: Metallothionein 2A (MT2A) was downregulated in the tumor tissues of patients with CRC compared to adjacent normal tissues and was related to the tumor M stage of patients. MT2A overexpression inhibited CRC cell proliferation and migration in cells, as well as growth and metastasis in CRC animal models. While knockdown of MT2A had the opposite effect in cells. Western blotting confirmed that MT2A overexpression promoted the phosphorylation of MST1, LAST2 and YAP1, thereby inhibiting the Hippo signaling pathway. Additionally, specific inhibitors of MST1/2 inhibited MT2A overexpression-mediated phosphorylation and relieved the inhibition of the Hippo signaling pathway, thus promoting cell proliferation. Immunohistochemistry in subcutaneous grafts and liver metastases further confirmed this result.

Conclusions: Our results suggested that MT2A is involved in CRC growth and liver metastasis. Therefore, MT2A and MST1 may be potential therapeutic targets for patients with CRC, especially those with liver metastases.

Citing Articles

Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer.

Wang Y, Yang Z, Li Z, Huang L, Hou S, Wang J BMC Cancer. 2025; 25(1):480.

PMID: 40089671 DOI: 10.1186/s12885-025-13882-x.

MT2A promotes angiogenesis in chronically ischemic brains through a copper-mitochondria regulatory mechanism.

Mo N, Tai C, Yang Y, Ling C, Zhang B, Wei L J Transl Med. 2025; 23(1):162.

PMID: 39915841 PMC: 11800420. DOI: 10.1186/s12967-025-06163-5.

Somatic mutation as an explanation for epigenetic aging.

Koch Z, Li A, Evans D, Cummings S, Ideker T Nat Aging. 2025; .

PMID: 39806003 DOI: 10.1038/s43587-024-00794-x.

Association between urinary metallothionein concentration and causes of death among cadmium-exposed residents in Japan: a 35-year follow-up study.

Li L, Okamoto R, Sun X, Kido T, Nogawa K, Suwazono Y Environ Health Prev Med. 2025; 30():1.

PMID: 39779248 PMC: 11744029. DOI: 10.1265/ehpm.24-00176.

Zinc and its binding proteins: essential roles and therapeutic potential.

Kiouri D, Chasapis C, Mavromoustakos T, Spiliopoulou C, Stefanidou M Arch Toxicol. 2024; 99(1):23-41.

PMID: 39508885 DOI: 10.1007/s00204-024-03891-3.

References

Tong M, Lu W, Liu H, Wu J, Jiang M, Wang X . Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer. Biomed Res Int. 2019; 2019:2957821. PMC: 6662468. DOI: 10.1155/2019/2957821. View

Shimizu M, Koma Y, Sakamoto H, Tsukamoto S, Kitamura Y, Urakami S . Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression. Cancers (Basel). 2021; 13(18). PMC: 8464741. DOI: 10.3390/cancers13184552. View

Zaman M, Barman S, Corley S, Wilkins M, Malladi C, Wu M . Transcriptomic insights into the zinc homeostasis of MCF-7 breast cancer cells via next-generation RNA sequencing. Metallomics. 2021; 13(6). DOI: 10.1093/mtomcs/mfab026. View

Arriaga J, Levy E, Bravo A, Bayo S, Amat M, Aris M . Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival. Hum Pathol. 2011; 43(2):197-208. DOI: 10.1016/j.humpath.2011.04.015. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Li D, Bao J, Yao J, Li J . lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling. Am J Transl Res. 2020; 12(9):5670-5682. PMC: 7540120. View

Furi I, Kalmar A, Wichmann B, Spisak S, Scholler A, Bartak B . Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line. PLoS One. 2015; 10(7):e0131699. PMC: 4489610. DOI: 10.1371/journal.pone.0131699. View

Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Piotrowska A, Prus R . Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol. 2012; 94(1):301-8. DOI: 10.1016/j.yexmp.2012.10.006. View

Mulder T, Janssens A, Verspaget H, van Hattum J, Lamers C . Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer. J Hepatol. 1992; 16(3):346-50. DOI: 10.1016/s0168-8278(05)80667-1. View

10.

Aquime J, Zampieri L, da Silva Kataoka M, Ribeiro N, Jaeger R, da Silva A . Metallothionein Expression and its Influence on the In Vitro Biological Behavior of Mucoepidermoid Carcinoma. Cells. 2020; 9(1). PMC: 7016984. DOI: 10.3390/cells9010157. View

11.

Ullio C, Brunk U, Urani C, Melchioretto P, Bonelli G, Baccino F . Autophagy of metallothioneins prevents TNF-induced oxidative stress and toxicity in hepatoma cells. Autophagy. 2015; 11(12):2184-98. PMC: 4835206. DOI: 10.1080/15548627.2015.1106662. View

12.

Ma S, Meng Z, Chen R, Guan K . The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2018; 88:577-604. DOI: 10.1146/annurev-biochem-013118-111829. View

13.

Ma D, Zhou Z, Yang B, He Q, Zhang Q, Zhang X . Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining. Oncol Lett. 2015; 10(4):2185-2191. PMC: 4579815. DOI: 10.3892/ol.2015.3556. View

14.

Liu X, Jiao T, Wang Y, Su W, Tang Z, Han C . WITHDRAWN: Long non-coding RNA GAS5 acts as a molecular sponge to regulate miR-23a in gastric cancer. Minerva Med. 2016; . View

15.

Yao B, Wang L, Wang H, Bao J, Li Q, Yu F . Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma. Aging (Albany NY). 2021; 13(8):11381-11410. PMC: 8109098. DOI: 10.18632/aging.202831. View

16.

Meng J, Su R, Liao Y, Li Y, Li L . Identification of 10 Hub genes related to the progression of colorectal cancer by co-expression analysis. PeerJ. 2020; 8:e9633. PMC: 7664468. DOI: 10.7717/peerj.9633. View

17.

Lin S, Wang X, Pan Y, Tian R, Lin B, Jiang G . Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A. Clin Cancer Res. 2018; 25(3):1050-1062. DOI: 10.1158/1078-0432.CCR-18-1281. View

18.

Habel N, Hamidouche Z, Girault I, Patino-Garcia A, Lecanda F, Marie P . Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis. 2013; 4:e874. PMC: 3920934. DOI: 10.1038/cddis.2013.405. View

19.

Thompson B . YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy. Bioessays. 2020; 42(5):e1900162. DOI: 10.1002/bies.201900162. View

20.

Marikar F, Jin G, Sheng W, Ma D, Hua Z . Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation. Chin Clin Oncol. 2017; 5(6):76. DOI: 10.21037/cco.2016.11.03. View